DUBLIN--(BUSINESS WIRE)--The "Liraglutide and Semaglutide Market by Type, by Route of Administration, by Application, by Distribution Channel, and by Region" report has been added to ...

Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...

Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

The first trial, PIONEER 4, set the new drug against Novo’s own product, injectable once a week Victoza. Semaglutide performed better than expected against Victoza. The results included ...